Lexicon Pharmaceuticals, Inc. (LXRX) Free cash flow 2016–2025
Lexicon Pharmaceuticals, Inc. (LXRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$67.9MFY2025 · since FY2016: -$175.9M → -$67.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.9M | +62.3% |
| FY2024 | -$179.8M | -10.7% |
| FY2023 | -$162.4M | -80.1% |
| FY2022 | -$90.2M | -2.2% |
| FY2021 | -$88.2M | +38.3% |
| FY2020 | -$143.1M | -225.8% |
| FY2019 | $113.7M | +176.5% |
| FY2018 | -$148.7M | +19.9% |
| FY2017 | -$185.6M | -5.6% |
| FY2016 | -$175.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice